Allen & Buckeridge is a venture capital firm dedicated to investing in and helping build global companies of significant and lasting value. Allen & Buckeridge focuses on early and expansion-stage investing in the Australia and Asia-Pacific regions. Examples of these include: enterprise software and services, communications & security, semiconductors and wireless applications. Investments range in size from as little as $100,000 to as much as $10 or $15 million. Allen & Buckeridge currently manages approximately $280 million spread across several funds. Allen & Buckeridge's investors include some of the largest superannuation funds and institutions in Australia as well as strategic overseas corporations such as IBM. Since their inception in 1996, Allen & Buckeridge have invested in over 45 technology companies, a number of which have since been listed on public markets or sold in successful trade sales.

Uniseed is a $61m joint venture pre-seed and seed stage venture capital fund, with the aim to successfully commercialise the outcomes of Australian research and ingenuity from the University of Queensland, the University of Melbourne and the University of New South Wales. Uniseed makes targeted investments at the earliest stages of a venture's formation and manages the development of research and ingenuity-based ventures to the point where they can secure substantial further investment from the investment community. It represents an important step in forging a link between academia and business that focuses on the commercialisation of innovative ideas and inventions for global consumption.

NewSouth Innovations Pty Limited (NSi) commercialises research and technology developed by the University of New South Wales.

NSi is a company limited by shares, and is a wholly owned subsidiary and controlled entity of UNSW. Formally Unisearch Limited, the organisation was restructured in 2005 and NSi was formed with a business model clearly focused on intellectual property (IP) commercialisation and technology transfer. NSi is located within the Research Precinct on the Kensington campus of UNSW.

Their primary function is to manage and commercialise the intellectual property of UNSW. This typically involves the protection of IP through patents and other forms of protection, the licensing of that technology and the raising of capital through the formation of spin-off companies.

The breadth of experience at NSi enables effective development of business relationships and strategic alliances with key partners in relevant industry sectors. NSi has an independent Board of Directors made up of representatives from the academic and investment communities.

NSi has a technology commercialisation team for physical sciences, which includes IT, engineering and photovoltaics; and a team for life sciences. We also have a team of business analysts, legal specialists and an accounts department; all supported by our administration, operations and public relations staff.

NSi forms spin out companies as a key commercialisation strategy. NSi retains an interest in these companies through equity or licence. These companies proudly work with technologies developed at UNSW.